Pharmaceuticals

A plethora of new weight-loss drugs are now available in the U.S., but they aren’t necessarily the same. Here’s a guide to the latest GLP-1 receptor agonists

Researchers have doubted how useful AI protein-structure tool AlphaFold will be in discovering medicines—now they are learning how to deploy it effectively

It’s a longstanding government failure to never use federal “march-in” licensing rights to lower drug prices. It’s also a mistake to limit them to only a few cases

Bad diets, stress, impaired sleep and aging can’t be reversed by juicing, healing crystals or influencer-endorsed pills. Don’t buy them

The allergy and asthma drug montelukast, also known as Singulair, can cause psychiatric side effects—and researchers aren’t sure why

Prescription drugs and vaccines have revolutionized healthcare, but how do researchers and industry decide what diseases to pursue?

Ozempic and similar drugs are ushering in a new era of weight management and obesity treatments, and researchers are racing to understand their impact

A loophole in FDA processes means older drugs such as those in oral decongestants weren’t properly tested. Here’s how we learned the most popular one doesn’t work

A deep-learning algorithm helped identify new compounds that are effective against antibiotic-resistant infections in mice, opening the door to AI-guided drug discovery

The active ingredient in Wegovy and Ozempic reduced the risk of heart attacks and strokes in a large trial of people with cardiovascular disease who were considered overweight or had obesity, but the cost and side effects remain barriers

Recent studies evaluate risks associated with drugs such as Wegovy and Mounjaro

Insurance plans could cover blockbuster weight-loss medications such as Wegovy and Ozempic, but the benefits may not be accessible to everyone